Weight‑loss surgery debate reignited after singer’s lap‑band scare
Singer Carnie Wilson was readmitted to a U.S. hospital after complications following laparoscopic adjustable gastric band removal, prompting renewed discussion about bariatric surgery versus GLP‑1 weight‑loss drugs. The Fox News report cites new JAMA research finding bariatric surgery yields greater long‑term weight loss and lower costs than GLP‑1 therapy, and includes surgeon commentary on comparative outcomes, typical percent weight loss, and device‑specific complication risks such as erosion, obstruction and ulcers.
Health
Science
🔍 Key Facts
- Carnie Wilson (57) was readmitted after lap‑band removal for high blood pressure, swelling, an ulcer and an obstruction with food inside the lap band, per her Instagram post quoted in the article.
- A JAMA study cited in the piece found bariatric surgery offers greater weight loss and lower costs over time compared with GLP‑1 medications.
- Clinicians quoted: gastric sleeve/bypass patients typically lose about 25%–35% of total body weight and keep most off for years; GLP‑1 drugs (Wegovy, Zepbound) typically produce 15%–22% weight loss while on therapy.
- Surgeons warn lap bands are increasingly regarded as outdated due to long‑term irritation and erosion, and that bariatric surgery can rapidly improve diabetes (patients off insulin within 48 hours in some cases).